

BackTable Urology
1.4K posts

@_backtableUro
The podcast for all things Urology to help you advance your practice. It's the meeting after the meeting. #UroSoMe #MedEd Visit our website to listen!





Not all NMIBC requires aggressive treatment. In this clip, Drs. Vignesh Packiam, Mark Tyson, and Sarah Psutka discuss de-escalation strategies for intermediate-risk disease, including surveillance, office fulguration, and thoughtful use of intravesical therapy. This podcast is supported by Ferring Pharmaceuticals. #URO277 #Urology #UrologicOncology #NMIBC #BladderCancer





When patients present with both bladder and upper tract high-risk disease, what gets treated first? Drs. Vignesh Packiam, Mark Tyson, and Sarah Psutka debate sequencing strategies, balancing oncologic risk, disease recurrence, and organ preservation. This podcast is supported by Ferring Pharmaceuticals. #URO277 #Urology #UrologicOncology #NMIBC #BladderCancer







When should venous tumor thrombus in RCC be managed urgently? This week, @vidit_sharma_ joins @DSRoberson93 to discuss embolic risk, patient optimization, and practical decision-making in managing venous tumor thrombus in renal cell carcinoma #URO300 @MayoUrology na2.hubs.ly/H059Yh00

Drs. Vignesh Packiam, Mark Tyson, and Sarah Psutka discuss strategies for managing difficult bladder symptoms in patients pursuing bladder preservation, and when those efforts may reach their limits. This podcast is supported by Ferring Pharmaceuticals. #URO277 #Urology #UrologicOncology #NMIBC #BladderCancer











